Details of the Drug

General Information of Drug (ID: DM3OMDV)

Drug Name
XL-888
Synonyms SCHEMBL17313415; QC-9274
Indication
Disease Entry ICD 11 Status REF
Solid tumour/cancer 2A00-2F9Z Phase 1 [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
Chemical Identifiers
Formula
C29H37N5O3
Canonical SMILES
CCC(C)NC1=C(C=C(C(=C1)C(=O)NC2CC3CCC(C2)N3C4=NC=C(C=C4)C(=O)C5CC5)C)C(=O)N
InChI
1S/C29H37N5O3/c1-4-17(3)32-25-14-23(16(2)11-24(25)28(30)36)29(37)33-20-12-21-8-9-22(13-20)34(21)26-10-7-19(15-31-26)27(35)18-5-6-18/h7,10-11,14-15,17-18,20-22,32H,4-6,8-9,12-13H2,1-3H3,(H2,30,36)(H,33,37)/t17-,20?,21-,22+/m1/s1
InChIKey
LHGWWAFKVCIILM-AMZGXZFVSA-N
Cross-matching ID
PubChem CID
60147023
CAS Number
1149705-71-4
TTD ID
D0J2RV
Combinatorial Drugs (CBD) Click to Jump to the Detailed CBD Information of This Drug

References

1 ClinicalTrials.gov (NCT00796484) Safety Study of Pharmacokinetics of XL888 in Adults With Solid Tumors. U.S. National Institutes of Health.